Paraganglioma, Malignant
4 clinical trials · Condition
◉ Watch Paraganglioma, Malignant
| Record | Firm | Date |
|---|---|---|
| The Efficacy and Safety of Penpulimab in the Treatment of Metastatic PPGL Patients Who Fail to Other Systemic Treatment (NCT05885399) | Peking Union Medical College Hospital | 2023-04-01 |
| Prediction and Evaluation of Anlotinib Treatment Response Using Contrast Enhanced Ultrasound PPGL Patients (NCT06015061) | Peking Union Medical College Hospital | 2023-03-01 |
| The Efficacy and Safety of Anlotinib in Patients With Metastatic Pheochromocytoma or Paraganglioma (NCT04860700) | Peking Union Medical College Hospital | 2021-04-30 |
| The Efficacy and Safety of Temozolomide in Patients With MPPGL (NCT05858177) | Peking Union Medical College Hospital | 2019-10-01 |
Track Paraganglioma, Malignant automatically
Every clearance here is in the API, with alerts when new ones post.